Radiographic examination of the breast has been so improved that it became a routine complement to physicalexamination. From November 1, 1983 through Sept.30, 1984, 684 patient with complaints of various breast problemwere examined by low-dose film mammography at Yong Done Hospital, Yonesei University. Among them, a comparativestudies, independently conducted physical examination, 97 cases of film mammography, 35 cases of ultrasoundmammography, 16 cases of aspiration cytology, and 3 cases of galactography were performed for our pathologicallyproven 98 cases of breast disease. Combined and complementary studies for breast diseases were analyzed in 37proven cases and authors found that specificity of those combined immediate complementary study techniques forbreast disease were 94% under colose cooperation with surgeon in Yong Dong Hospital, Yonsei University.
Breast Diseases ; Breast ; Complement System Proteins ; Humans ; Mammography ; Methods ; Physical Examination ; Sensitivity and Specificity

No abstract available.
Rectal Neoplasms* ; Recurrence*

No abstract available.
Gastrectomy* ; Stomach Neoplasms*

No abstract available.
Humans

From Oct. 1, 1983 to May 31, 1988, 6198 mammograms were taken and 443 mastectomies were performed at the Yonsei University Hospital, Seoul, Korea. Of these, 191 cases had preoperative mammography performed prior to surgery (study group) and 252 cases underwent mastectomies without preoperative mammography (control group). There were no significant differences between the two groups in pathological stages, axillary lymph node metastasis and size of the tumor, suggesting that little benefit is derived from the preoperative mammography in the hospital setting. However, there were a number of other findings, including a 14% incidence of multiple foci and localization of non-palpable cancer in 3% of cases, that could help us to make therapeutic plans and strategies for these patients.
Breast Neoplasms/pathology/*radiography/surgery ; Female ; Hospitalization ; Human ; Lymphatic Metastasis ; *Mammography ; Preoperative Care ; Prospective Studies

No abstract available.
Breast* ; Hamartoma*

The cathepsin D is a lysosomal protease secreted in excess by breast cancer cells. The function of this enzyme is degradation of the extracellular matrix and proteoglycan. It is induced by estrogens in estrogen receptor positive breast cancer cell lines. On the basis of this, cathepsin D expression in breast cancer cells seems to be correlated with the prognosis. But there is debates in its prognostic significance. Relationship between cathepsin D expression and other prognostic factors of breast cancer was studied. We investigated 51 cases of invasive ductal cell carcinoma of breast removed by open biopsy or mastectomy. All cases were fixed in formalin and embedded in paraffin. We used 46-KD intermediate form of the enzyme for cathepsin D expression on immunohistochemical stain. We observed no significant correlation with age, stage, histologic grade, lymphatic invasion, and estrogen receptor status. Cathepsin D may be an independent factor which is not related with other prognostic factors, especially estrogen receptor status.
Biopsy ; Breast Neoplasms

Among the 1760 cases of carcinomas of the breast treated between 1981 and 1996, there were 31 cases of bilateral breast cancer. Of these, 7 were synchronous tumors and the remaining 24 patients had metachronous tumors : 41.7% of all patients had presented within 5 years since the first primary tumors were detected and 73.3% of all patients had presented within 10 years. The mean age of the synchronous bilateral cancers was 39.9 (26~55), and the mean age at the diagnosis of the first cancers in the metachronous cancers was 44.75 (31~70) years old. The location of the tumor was the same in 64% and 68% of the synchronous and metachronous cancers, respectively, that had an identified histology. The mean survival of metachronous group was 70.5 months and that of synchronous group was 114.7 months. However, there was no statistical significance between the mean survival times of the two groups (p>0.05). We recommend a careful check-up for the opposite breast at the time of primary cancer treatment, as well as well an organized follow-up program for all patients having undergone treatment for breast cancer. Further investigations are required to determine the incidence of and risk factors for second cancer development in the opposite breast.
Breast Neoplasms* ; Breast* ; Diagnosis ; Follow-Up Studies ; Humans ; Incidence ; Neoplasms, Second Primary ; Risk Factors ; Survival Rate

No abstract available.
Humans ; Microcomputers* ; Survival Analysis*

No abstract available.
Humans ; Lymphocytes* ; Stomach Neoplasms* ; Stomach*